Ketanserin versus nifedipine in secondary Raynaud's phenomenon. - Suppr | 超能文献

Ketanserin versus nifedipine in secondary Raynaud's phenomenon.

作者信息

Kirch W, Linder H R, Hutt H J, Ohnhaus E E, Mahler F

出版信息

Vasa. 1987;16(1):77-80.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Ketanserin versus nifedipine in secondary Raynaud's phenomenon.

Vasa. 1987;16(1):77-80.

2

Controlled comparison of ketanserin and nifedipine in Raynaud's phenomenon.

Angiology. 1989 Feb;40(2):114-21. doi: 10.1177/000331978904000206.

3

[The effect of nifedipine (Adalat) on Raynaud's phenomenon].硝苯地平（拜新同）对雷诺现象的作用

Ugeskr Laeger. 1983 Dec 5;145(49):3814-6.

4

Does serotonin receptor blockade have a therapeutic effect in Raynaud's phenomenon?血清素受体阻断对雷诺现象有治疗作用吗？

Vasa Suppl. 1987;18:64-7.

5

Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.酮色林对进行性系统性硬化症中雷诺现象的影响：一项双盲试验。

Drugs Exp Clin Res. 1985;11(9):659-63.

6

Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.钙通道阻滞剂硝苯地平对雷诺现象的影响。一项对照双盲试验。

J Rheumatol. 1984 Jun;11(3):362-4.

7

[Use of nifedipine in patients with Raynaud's phenomenon].硝苯地平在雷诺现象患者中的应用

Kardiol Pol. 1987;30 Suppl:97-105.

8

[The use of capillary videomicroscopy in the therapeutic assessment of acral vasospastic phenomena: microcirculatory effect of ketanserin and nifedipine].[毛细血管显微镜检查在肢端血管痉挛现象治疗评估中的应用：酮色林和硝苯地平的微循环效应]

Schweiz Rundsch Med Prax. 1994 Apr 26;83(17):511-4.

9

Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.硝苯地平治疗雷诺现象的对照双盲试验。

N Engl J Med. 1983 Apr 14;308(15):880-3. doi: 10.1056/NEJM198304143081507.

10

Responses to nifedipine by patients with Raynaud's disease and Raynaud's phenomenon secondary to another disease.患有雷诺病以及继发于其他疾病的雷诺现象的患者对硝苯地平的反应。

Clin Ther. 1987;9(2):232-7.

引用本文的文献

1

Calcium channel blockers for primary and secondary Raynaud's phenomenon.用于原发性和继发性雷诺现象的钙通道阻滞剂。

Cochrane Database Syst Rev. 2017 Dec 13;12(12):CD000467. doi: 10.1002/14651858.CD000467.pub2.

2

Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis.酮色林治疗进行性系统性硬化症中的雷诺现象。

Cochrane Database Syst Rev. 2000;1998(2):CD000954. doi: 10.1002/14651858.CD000954.

3

Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.酮色林。对其药效学和药代动力学特性以及在高血压和外周血管疾病中的治疗潜力的综述。

Drugs. 1990 Dec;40(6):903-49. doi: 10.2165/00003495-199040060-00010.